JP2015213501A5 - - Google Patents

Download PDF

Info

Publication number
JP2015213501A5
JP2015213501A5 JP2015088066A JP2015088066A JP2015213501A5 JP 2015213501 A5 JP2015213501 A5 JP 2015213501A5 JP 2015088066 A JP2015088066 A JP 2015088066A JP 2015088066 A JP2015088066 A JP 2015088066A JP 2015213501 A5 JP2015213501 A5 JP 2015213501A5
Authority
JP
Japan
Prior art keywords
composition
composition according
individual
functional
acid bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015088066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015213501A (ja
JP6035578B2 (ja
Filing date
Publication date
Priority claimed from US14/259,442 external-priority patent/US10967013B2/en
Priority claimed from US14/690,502 external-priority patent/US10188684B2/en
Application filed filed Critical
Publication of JP2015213501A publication Critical patent/JP2015213501A/ja
Publication of JP2015213501A5 publication Critical patent/JP2015213501A5/ja
Application granted granted Critical
Publication of JP6035578B2 publication Critical patent/JP6035578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015088066A 2014-04-23 2015-04-23 乳酸菌、それを含む組成物及びそれらの使用 Active JP6035578B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14/259,442 US10967013B2 (en) 2014-04-23 2014-04-23 Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the same
US14/259,442 2014-04-23
US14/690,502 2015-04-20
US14/690,502 US10188684B2 (en) 2015-04-20 2015-04-20 Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium

Publications (3)

Publication Number Publication Date
JP2015213501A JP2015213501A (ja) 2015-12-03
JP2015213501A5 true JP2015213501A5 (enExample) 2016-01-28
JP6035578B2 JP6035578B2 (ja) 2016-11-30

Family

ID=53008330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015088066A Active JP6035578B2 (ja) 2014-04-23 2015-04-23 乳酸菌、それを含む組成物及びそれらの使用

Country Status (5)

Country Link
EP (1) EP2937424B1 (enExample)
JP (1) JP6035578B2 (enExample)
CN (1) CN105002109B (enExample)
ES (1) ES2624673T3 (enExample)
PL (1) PL2937424T3 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6933358B2 (ja) * 2016-04-06 2021-09-08 東海漬物株式会社 美肌促進剤
EP3487985B1 (en) * 2016-07-19 2023-11-08 Bened Biomedical Co., Ltd. Method for preventing or treating movement disorders with lactic acid bacterium
KR20180019474A (ko) * 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
CN107050062A (zh) * 2016-11-08 2017-08-18 江西益盟科技有限公司 治疗便秘的乳酸菌组合物及其制备方法
MY199866A (en) * 2017-01-13 2023-11-26 Bened Biomedical Co Ltd A novel lactic acid bacteria and its applications
KR102089836B1 (ko) * 2017-03-15 2020-03-16 (주)바이오일레븐 트립토판분해효소 음성균과 인터페론 감마 형성을 유도하는 균주를 이용한 염증성 질환 예방 및 치료용 약학적 조성물 또는 이를 이용한 치료방법
CN106906165B (zh) * 2017-04-25 2020-07-24 重庆第二师范学院 一种植物乳杆菌及其在制备预防便秘的食品中的应用
CN107267416A (zh) * 2017-07-05 2017-10-20 重庆第二师范学院 植物乳杆菌ys2及其在制备预防便秘的食品中的应用
WO2019119261A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
KR102741244B1 (ko) * 2017-12-19 2024-12-11 인터내셔널 엔&에이치 덴마크 에이피에스 인지 및 정신 건강을 위한 프로바이오틱스
KR102265538B1 (ko) 2018-02-02 2021-06-16 주식회사 고바이오랩 락토바실러스 플란타럼 kbl396 균주 및 그 용도
CN111035661A (zh) * 2018-10-15 2020-04-21 深圳市华大农业应用研究院 植物乳杆菌的用途
TWI731279B (zh) 2018-11-21 2021-06-21 葡萄王生技股份有限公司 發酵乳桿菌gkf3、含其之組合物及改善精神失調之用途
ES2763350B2 (es) * 2018-11-28 2020-10-13 Consejo Superior Investigacion Cepa de christensenella minuta y uso de la misma
WO2020115206A1 (en) * 2018-12-06 2020-06-11 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
US11612624B2 (en) 2019-01-28 2023-03-28 Bened Biomedical Co., Ltd. Method for protecting a subject for exercise
BR112021014935A2 (pt) * 2019-02-01 2021-09-28 Bened Biomedical Co., Ltd. Método para prevenir ou tratar uma emoção ou comportamento anormal em um animal não humano por meio de bactéria ácido-láctica
CA3127726A1 (en) * 2019-02-01 2020-08-06 Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement Lactococcus lactis strains for the prevention and/or the treatment of visceral pain
KR102148707B1 (ko) * 2019-02-22 2020-08-31 한국식품연구원 우울증 및 불안장애의 예방, 개선 또는 치료 효능을 갖는 김치 유산균 락토바실러스 사케아이
WO2021155543A1 (en) * 2020-02-06 2021-08-12 Lee Wang Tso Composition of lactic acid bacterium for use in preventing or treating rett syndrome
EP4106780A4 (en) * 2020-03-25 2023-08-23 Bened Biomedical Co., Ltd. PROCEDURES FOR REDUCING BEHAVIORAL ANOMALIES
TWI826851B (zh) * 2020-10-22 2023-12-21 國立臺灣大學 植物乳酸桿菌植物亞種ps128於製備治療芳香族l-胺基酸脫羧基酶缺乏症的藥物的用途
TW202241477A (zh) * 2020-12-16 2022-11-01 日商明治股份有限公司 腦組織之發炎改善用組成物
CN113215018A (zh) * 2021-02-04 2021-08-06 郑州大学 一株植物乳杆菌植物亚种及其在豆粕和北艾混合发酵中的应用
CN113564084A (zh) * 2021-08-13 2021-10-29 华东理工大学 植物乳杆菌x7022在预防和治疗便秘上的应用
TWI810645B (zh) * 2021-09-06 2023-08-01 景岳生物科技股份有限公司 乳桿菌組合物及其改善抗生素造成之焦慮症的用途
KR20250095634A (ko) * 2022-10-28 2025-06-26 시에이치알. 한센 에이/에스 과민성 대장 증후군 증상 해결에 사용되기 위한 락티플란티바실러스 플란타룸
CN117143760B (zh) * 2023-07-12 2024-09-20 西南大学 一株能促进5-htp分泌及缓解抑郁的鼠李糖乳酪杆菌ky16及其应用
KR102741129B1 (ko) * 2023-11-07 2024-12-11 농업회사법인 고려홍삼원 주식회사 락토바실러스 플란타룸 ckh-01 균주를 포함하는 스트레스 완화 및 수면개선용 프로바이오틱스 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725853A (en) * 1994-10-18 1998-03-10 Pioneer Hi-Bred International, Inc. 4 strain direct-fed microbial
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP2332539A4 (en) * 2008-08-21 2012-05-09 Suntory Holdings Ltd PHARMACEUTICAL PREPARATION, FOOD OR BEVERAGE WITH ANTICIPATIVE EFFECT ON THE SEROTONINE TRANSPORTER

Similar Documents

Publication Publication Date Title
JP2015213501A5 (enExample)
Jiang et al. Evaluation of probiotic properties of Lactobacillus plantarum WLPL04 isolated from human breast milk
Hojjati et al. Aggregation, adherence, anti-adhesion and antagonistic activity properties relating to surface charge of probiotic Lactobacillus brevis gp104 against Staphylococcus aureus
Sokovic Bajic et al. GABA-producing natural dairy isolate from artisanal zlatar cheese attenuates gut inflammation and strengthens gut epithelial barrier in vitro
Nueno-Palop et al. Probiotic assessment of Enterococcus faecalis CP58 isolated from human gut
Wang et al. Swine-derived probiotic Lactobacillus plantarum inhibits growth and adhesion of enterotoxigenic Escherichia coli and mediates host defense
Álvarez-Cisneros et al. Antibiotic resistance in lactic acid bacteria
EP4272815A3 (en) New medical use of probiotics
Brisbin et al. Effects of lactobacilli on cytokine expression by chicken spleen and cecal tonsil cells
Mirzaei et al. Antimicrobial properties of lactic acid bacteria isolated from traditional yogurt and milk against Shigella strains
Matsuzaki et al. Immunomodulating activity of exopolysaccharide‐producing Leuconostoc mesenteroides strain NTM048 from green peas
Zhang et al. Antagonistics against pathogenic Bacillus cereus in milk fermentation by Lactobacillus plantarum ZDY2013 and its anti-adhesion effect on Caco-2 cells against pathogens
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
Bosch et al. Probiotic properties of Lactobacillus plantarum CECT 7315 and CECT 7316 isolated from faeces of healthy children
Helmy et al. In vitro evaluation of the impact of the probiotic E. coli Nissle 1917 on Campylobacter jejuni’s invasion and intracellular survival in human colonic cells
RU2010142003A (ru) Синбиотическая смесь
RU2016143921A (ru) Композиция для применения в лечении или предупреждении вирусных или бактериальных инфекций у субъекта, проходящего противоопухолевую химиотерапию, лечение лейкоза или лечение СПИД, содержащая l.reuteri ler03 и/или l.salivarius ls06
Mandal et al. Isolation and characterization of lactobacilli from human faeces and indigenous fermented foods for their potential application as probiotics
JP2018532034A (ja) 機能性水和ヒアルロン酸及びこれを利用した優れた腸粘膜付着能及び選択的拮抗作用を有するコーティング乳酸菌の製造方法
Chang-Liao et al. Isolation of a Leuconostoc mesenteroides strain with anti-porcine epidemic diarrhea virus activities from kefir grains
Wu et al. Evaluation of the probiotic potential of Lactobacillus delbrueckii ssp. indicus WDS-7 isolated from Chinese traditional fermented buffalo milk in vitro
RU2016143922A (ru) Терапевтическое средство для применения в лечении опухолей, синдрома приобретенного иммунодефицита и лейкозов путем двойной иммунной биостимуляции
Lim Anti-Helicobacter pylori activity of antimicrobial substances produced by lactic acid bacteria isolated from Baikkimchi
Nawaz et al. Screening and characterization of new potentially probiotic lactobacilli from breast-fed healthy babies in Pakistan
Sim et al. In vitro assessment of the gastrointestinal tolerance and immunomodulatory function of Bacillus methylotrophicus isolated from a traditional Korean fermented soybean food